Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2015 (2015), Article ID 618631, 9 pages
http://dx.doi.org/10.1155/2015/618631
Research Article

Transplanted Neural Stem Cells: Playing a Neuroprotective Role by Ceruloplasmin in the Substantia Nigra of PD Model Rats?

1Department of Neurology, Shanghai First People’s Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200080, China
2School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240, China

Received 29 March 2015; Revised 15 May 2015; Accepted 17 May 2015

Academic Editor: Ryuichi Morishita

Copyright © 2015 Jia-Jia Xiao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. X. Tan, L. Zhang, H. Zhu et al., “Brn4 and TH synergistically promote the differentiation of neural stem cells into dopaminergic neurons,” Neuroscience Letters, vol. 571, pp. 23–28, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. R. Pardal and J. López-Barneo, “Neural stem cells and transplantation studies in Parkinson's disease,” Advances in Experimental Medicine and Biology, vol. 741, pp. 206–216, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. T. Yasuhara, N. Matsukawa, K. Hara et al., “Transplantation of human neural stem cells exerts neuroprotection in a rat model of Parkinson's disease,” The Journal of Neuroscience, vol. 26, no. 48, pp. 12497–12511, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. K. B. Bjugstad, Y. D. Teng, D. E. Redmond Jr. et al., “Human neural stem cells migrate along the nigrostriatal pathway in a primate model of Parkinson's disease,” Experimental Neurology, vol. 211, no. 2, pp. 362–369, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. K. K. Meissner, D. L. Kirkham, and L. C. Doering, “Transplants of neurosphere cell suspensions from aged mice are functional in the mouse model of Parkinson's,” Brain Research, vol. 1057, no. 1-2, pp. 105–112, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. Q. F. Zhu, J. Ma, L. L. Yu, and C. G. Yuan, “Grafted neural stem cells migrate to substantia nigra and improve behavior in Parkinsonian rats,” Neuroscience Letters, vol. 462, no. 3, pp. 213–218, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. K. B. Bjugstad, D. E. Redmond Jr., Y. D. Teng et al., “Neural stem cells implanted into MPTP-treated monkeys increase the size of endogenous tyrosine hydroxylase-positive cells found in the striatum: a return to control measures,” Cell Transplantation, vol. 14, no. 4, pp. 183–192, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. D. M. Hermann, L. Peruzzotti-Jametti, J. Schlechter, J. D. Bernstock, T. R. Doeppner, and S. Pluchino, “Neural precursor cells in the ischemic brain—integration, cellular crosstalk, and consequences for stroke recovery,” Frontiers in Cellular Neuroscience, vol. 8, article 291, 2014. View at Publisher · View at Google Scholar
  9. C. Sun, H. Zhang, J. Li et al., “Modulation of the major histocompatibility complex by neural stem cell-derived neurotrophic factors used for regenerative therapy in a rat model of stroke,” Journal of Translational Medicine, vol. 8, article 77, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. K. J. Doorn, B. Drukarch, A. van Dam, and P. J. Lucassen, “Hippocampal proliferation is increased in presymptomatic Parkinson's disease and due to microglia,” Neural Plasticity, vol. 2014, Article ID 959154, 13 pages, 2014. View at Publisher · View at Google Scholar
  11. Z. H. Sun, Y. L. Lai, W. W. Zeng, D. Zhao, H. C. Zuo, and Z. P. Xie, “Neural stem/progenitor cells survive and differentiate better in PD rats than in normal rats,” Acta Neurochirurgica Supplement, vol. 87, pp. 169–174, 2003. View at Google Scholar
  12. V. Vassiliev, Z. L. Harris, and P. Zatta, “Ceruloplasmin in neurodegenerative diseases,” Brain Research Reviews, vol. 49, no. 3, pp. 633–640, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Olivieri, A. Conti, S. Iannaccone et al., “Ceruloplasmin oxidation, a feature of Parkinson's disease CSF, inhibits ferroxidase activity and promotes cellular iron retention,” Journal of Neuroscience, vol. 31, no. 50, pp. 18568–18577, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Rubio-Osornio, S. Montes, Y. Heras-Romero et al., “Induction of ferroxidase enzymatic activity by copper reduces MPP+-evoked neurotoxicity in rats,” Neuroscience Research, vol. 75, no. 3, pp. 250–255, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Ayton, P. Lei, P. A. Adlard et al., “Iron accumulation confers neurotoxicity to a vulnerable population of nigral neurons: implications for Parkinson’s disease,” Molecular Neurodegeneration, vol. 9, no. 1, article 27, 2014. View at Publisher · View at Google Scholar
  16. A. McNeill, M. Pandolfo, J. Kuhn, H. Shang, and H. Miyajima, “The neurological presentation of ceruloplasmin gene mutations,” European Neurology, vol. 60, no. 4, pp. 200–205, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. W.-J. Li, J.-F. Wang, and X.-P. Wang, “Wilson's disease: update on integrated Chinese and western medicine,” Chinese Journal of Integrative Medicine, vol. 19, no. 3, pp. 233–240, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Ayton, P. Lei, J. A. Duce et al., “Ceruloplasmin dysfunction and therapeutic potential for Parkinson disease,” Annals of Neurology, vol. 73, no. 4, pp. 554–559, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. Y. Yu and T. Wen, “Generation of dopaminergic neurons by fusion of neural stem cells and midbrain neurons,” Cellular and Molecular Biology, vol. 57, supplement, pp. OL1528–OL1533, 2011. View at Google Scholar
  20. X. Deng, Y. Liang, H. Lu et al., “Co-transplantation of GDNF-overexpressing neural stem cells and fetal dopaminergic neurons mitigates motor symptoms in a rat model of parkinson's disease,” PLoS ONE, vol. 8, no. 12, Article ID e80880, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. G. Paxinos and C. Watson, The Rat Brain Stereotaxic Coordinates, Academic Press, Sydney, Australia, 2006.
  22. L. Frau, M. Morelli, and N. Simola, “Performance of movement in hemiparkinsonian rats influences the modifications induced by dopamine agonists in striatal efferent dynorphinergic neurons,” Experimental Neurology, vol. 247, pp. 663–672, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. X.-X. Du, H.-M. Xu, H. Jiang, N. Song, J. Wang, and J.-X. Xie, “Curcumin protects nigral dopaminergic neurons by iron-chelation in the 6-hydroxydopamine rat model of Parkinson's disease,” Neuroscience Bulletin, vol. 28, no. 3, pp. 253–258, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Wang, H. Xu, H. Jiang, X. Du, P. Sun, and J. Xie, “Neurorescue effect of rosmarinic acid on 6-hydroxydopamine-lesioned nigral dopamine neurons in rat model of Parkinson's disease,” Journal of Molecular Neuroscience, vol. 47, no. 1, pp. 113–119, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. L. Li, C. Holscher, B.-B. Chen, Z.-F. Zhang, and Y.-Z. Liu, “Hepcidin treatment modulates the expression of divalent metal transporter-1, ceruloplasmin, and ferroportin-1 in the rat cerebral cortex and hippocampus,” Biological Trace Element Research, vol. 143, no. 3, pp. 1581–1593, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. Y. Li, Y. Sun, J. Yang, Y. Wu, J. Yu, and B. Li, “Age-dependent dopaminergic dysfunction following fetal exposure to atrazine in SD rats,” Environmental Toxicology and Pharmacology, vol. 37, no. 3, pp. 1275–1282, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Y. Lee, S. H. Kim, A.-R. Ko et al., “Therapeutic effects of repetitive transcranial magnetic stimulation in an animal model of Parkinson's disease,” Brain Research, vol. 1537, pp. 290–302, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. R. K. Leak, K. A. Garbett, A. M. Dettmer, Z. Zhang, K. Mirnics, and J. L. Cameron, “Physical activity is linked to ceruloplasmin in the striatum of intact but not MPTP-treated primates,” Cell and Tissue Research, vol. 350, no. 3, pp. 401–407, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Biebl, B. Winner, and J. Winkler, “Caspase inhibition decreases cell death in regions of adult neurogenesis,” NeuroReport, vol. 16, no. 11, pp. 1147–1150, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. J. Ourednik, V. Ourednik, W. P. Lynch, M. Schachner, and E. Y. Snyder, “Neural stem cells display an inherent mechanism for rescuing dysfunctional neurons,” Nature Biotechnology, vol. 20, no. 11, pp. 1103–1110, 2002. View at Publisher · View at Google Scholar · View at Scopus
  31. X. Zhang, J. Xiong, S. Liu et al., “Puerarin protects dopaminergic neurons in Parkinson's disease models,” Neuroscience, vol. 280, pp. 88–98, 2014. View at Publisher · View at Google Scholar
  32. C. Krabbe, S. T. Bak, P. Jensen et al., “Influence of oxygen tension on dopaminergic differentiation of human fetal stem cells of midbrain and forebrain origin,” PLoS ONE, vol. 9, no. 5, Article ID e96465, 2014. View at Publisher · View at Google Scholar · View at Scopus
  33. X.-L. Gu, C.-X. Long, L. Sun, C. Xie, X. Lin, and H. Cai, “Astrocytic expression of Parkinson's disease-related A53T-synuclein causes neurodegeneration in mice,” Molecular Brain, vol. 3, no. 1, article 12, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. D. Ziavra, G. Makri, P. Giompres et al., “Neural stem cells transplanted in a mouse model of Parkinson's disease differentiate to neuronal phenotypes and reduce rotational deficit,” CNS and Neurological Disorders—Drug Targets, vol. 11, no. 7, pp. 829–835, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. A. Wypijewska, J. Galazka-Friedman, E. R. Bauminger et al., “Iron and reactive oxygen species activity in parkinsonian substantia nigra,” Parkinsonism and Related Disorders, vol. 16, no. 5, pp. 329–333, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. R. L. Schroeder and J. P. Gerber, “A reappraisal of Fe(III) adsorption by melanin,” Journal of Neural Transmission, vol. 121, no. 12, pp. 1483–1491, 2014. View at Publisher · View at Google Scholar · View at Scopus
  37. G. Bartzokis, P. H. Lu, K. Tingus et al., “Gender and iron genes may modify associations between brain iron and memory in healthy aging,” Neuropsychopharmacology, vol. 36, no. 7, pp. 1375–1384, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. D. Kaur and J. Andersen, “Does cellular iron dysregulation play a causative role in Parkinson's disease?” Ageing Research Reviews, vol. 3, no. 3, pp. 327–343, 2004. View at Publisher · View at Google Scholar · View at Scopus
  39. M. R. Hennis, K. W. Seamans, M. A. Marvin, B. H. Casey, and M. S. Goldberg, “Behavioral and neurotransmitter abnormalities in mice deficient for Parkin, DJ-1 and superoxide dismutase,” PLoS ONE, vol. 8, no. 12, Article ID e84894, 2013. View at Publisher · View at Google Scholar · View at Scopus
  40. J. Kristinsson, J. Snaedal, G. Tórsdóttir, and T. Jóhannesson, “Ceruloplasmin and iron in Alzheimer's disease and Parkinson's disease: a synopsis of recent studies,” Neuropsychiatric Disease and Treatment, vol. 8, pp. 515–521, 2012. View at Publisher · View at Google Scholar · View at Scopus
  41. S. A. Schneider, P. Dusek, J. Hardy, A. Westenberger, J. Jankovic, and K. P. Bhatia, “Genetics and pathophysiology of neurodegeneration with brain iron accumulation (NBIA),” Current Neuropharmacology, vol. 11, no. 1, pp. 59–79, 2013. View at Google Scholar · View at Scopus
  42. T. Litwin, G. Gromadzka, G. M. Szpak, K. Jabłonka-Salach, E. Bulska, and A. Członkowska, “Brain metal accumulation in Wilson's disease,” Journal of the Neurological Sciences, vol. 329, no. 1-2, pp. 55–58, 2013. View at Publisher · View at Google Scholar · View at Scopus
  43. L. Batista-Nascimento, C. Pimentel, R. A. Menezes, and C. Rodrigues-Pousada, “Iron and neurodegeneration: from cellular homeostasis to disease,” Oxidative Medicine and Cellular Longevity, vol. 2012, Article ID 128647, 8 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  44. I. de Domenico, D. M. Ward, M. C. B. di Patti et al., “Ferroxidase activity is required for the stability of cell surface ferroportin in cells expressing GPI-ceruloplasmin,” The EMBO Journal, vol. 26, no. 12, pp. 2823–2831, 2007. View at Publisher · View at Google Scholar · View at Scopus
  45. K. Kaneko, A. Hineno, K. Yoshida, and S.-I. Ikeda, “Increased vulnerability to rotenone-induced neurotoxicity in ceruloplasmin-deficient mice,” Neuroscience Letters, vol. 446, no. 1, pp. 56–58, 2008. View at Publisher · View at Google Scholar · View at Scopus
  46. S. J. Texel, X. Xu, and Z. L. Harris, “Ceruloplasmin in neurodegenerative diseases,” Biochemical Society Transactions, vol. 36, no. 6, pp. 1277–1281, 2008. View at Publisher · View at Google Scholar · View at Scopus